Cargando…
Biallelic correction of sickle cell disease‐derived induced pluripotent stem cells (iPSCs) confirmed at the protein level through serum‐free iPS‐sac/erythroid differentiation
New technologies of induced pluripotent stem cells (iPSCs) and genome editing have emerged, allowing for the development of autologous transfusion therapies. We previously demonstrated definitive β‐globin production from human embryonic stem cell (hESC)‐derived erythroid cell generation via hemangio...
Autores principales: | Haro‐Mora, Juan J., Uchida, Naoya, Demirci, Selami, Wang, Qi, Zou, Jizhong, Tisdale, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7180291/ https://www.ncbi.nlm.nih.gov/pubmed/32034898 http://dx.doi.org/10.1002/sctm.19-0216 |
Ejemplares similares
-
Synthetic mRNAs Drive Highly Efficient iPS Cell Differentiation to Dopaminergic Neurons
por: Xue, Yingchao, et al.
Publicado: (2018) -
Human Genomic Safe Harbors and the Suicide Gene‐Based Safeguard System for iPSC‐Based Cell Therapy
por: Kimura, Yasuyoshi, et al.
Publicado: (2019) -
Patient-Specific iPSC-Derived Models Link Aberrant Endoplasmic Reticulum Stress Sensing and Response to Juvenile Osteochondritis Dissecans Etiology
por: Salazar-Noratto, Giuliana E, et al.
Publicado: (2023) -
Robust generation of erythroid and multilineage hematopoietic progenitors from human iPSCs using a scalable monolayer culture system
por: Ruiz, Juan Pablo, et al.
Publicado: (2019) -
Human iPSC differentiation to retinal organoids in response to IGF1 and BMP4 activation is line‐ and method‐dependent
por: Chichagova, Valeria, et al.
Publicado: (2019)